Related Experiment Video
Updated: Jan 31, 2026
Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi
Published on: September 28, 2022
Lyme Neuroborreliosis
Sebastian Rauer1, Stefan Kastenbauer, Volker Fingerle
1Department of Neurology and Neurophysiology, Medical Center-University of Freiburg; Neurologische Praxis, München; National Reference Centre for Borrelia, Bavarian Health and Food Safety Authority, Oberschleissheim; Institute for Laboratory Medicine, Microbiology and Hospital Hygiene, Krankenhaus Nordwest, Frankfurt/Main; Klinikum Bremen Mitte, Prof.-Hess-Kinderklinik and Clinic for Pediatric Intensive Care, Bremen; Evidence in Medicine / Cochrane Germany, Medical Center, Faculty of Medicine, University of Freiburg; *All of the editors, authors, and processors of the German S3 guideline on Lyme neuroborreliosis are listed in the eBox.
Early treatment of Lyme neuroborreliosis offers a favorable prognosis. Oral doxycycline is as effective as intravenous antibiotics for early stages, with shorter treatment durations proving sufficient and avoiding risks of prolonged therapy.
Area of Science:
- Infectious Diseases
- Neurology
- Evidence-Based Medicine
Background:
- The German S3 guideline provides evidence-based recommendations for diagnosing and treating Lyme neuroborreliosis.
- Lyme neuroborreliosis is a significant neurological manifestation of Borrelia infection.
Purpose of the Study:
- To update and disseminate scientifically grounded information on Lyme neuroborreliosis diagnosis and treatment.
- To guide physicians in managing Lyme neuroborreliosis effectively.
Main Methods:
- Systematic literature search conducted from March 2014 for 12 months.
- Searched Medline, Embase, and Cochrane Register using terms including "Lyme disease," "neuroborreliosis," and neurological manifestations.
- Publications were critically assessed by the German Cochrane Center.
Main Results:
- Oral doxycycline demonstrates equivalent efficacy to intravenous beta-lactam antibiotics for early Lyme neuroborreliosis (RR: 0.98, 95% CI: [0.68; 1.42]).
- A 14-day treatment course is sufficient for early Lyme neuroborreliosis.
- 14-21 days of treatment are generally adequate for late (chronic) Lyme neuroborreliosis.
Conclusions:
- Early diagnosis and treatment of Lyme neuroborreliosis lead to a favorable prognosis.
- Extended antibiotic therapy for chronic Lyme neuroborreliosis with nonspecific symptoms provides no added benefit.
- Prolonged antibiotic use increases the risk of adverse effects.
